Evaluation de la gêne Oculaire après Injections intravitréennes
Overview
- Phase
- Not Applicable
- Intervention
- Optive
- Conditions
- Macular Degeneration
- Sponsor
- Centre Hospitalier Intercommunal Creteil
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Comparison of the overall scores of the ocular discomfort questionnaire after the 2 first intravitreal injection in naïve patients
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
In this study, ocular discomfort following intravitreal injection in naïve patients will be studied, as well as the efficacy of wetting agent (Optive eyewash) to prevent ocular discomfort.
Detailed Description
In naive patients, the two first intravitreal injections will be studied. Within the first injection, no wetting agent will be delivered. Within 72hours after this first intravitreal injections, patients will be contacted by phone by a nurse to complete questionnaires on quality of life and on ocular pain and eye discomfort. After the second injection, a treatment with wetting agent will be prescribed. With 72hours after the second injection, quality of life, ocular discomfort as well as acceptability and tolerance of the eye drops will also be assessed by a phone questionnaire.
Investigators
Oudy SEMOUN
Doctor in ophtalmology
Centre Hospitalier Intercommunal Creteil
Eligibility Criteria
Inclusion Criteria
- •Patient over 18 years old
- •Patient with social healthcare
- •Patient understanding French language
- •Patient requiring anti-VEGF treatment by intravitreal injection
Exclusion Criteria
- •Patient treated by Ozurdex® before
- •Patient with known and treated ocular dryness
- •Non naive patient for intravitreal injection
- •Hypersensitivity to Carmellose
- •Patient who received wetting agent within the 3 last months
- •History of povidone-iodine allergy
- •Pregnant or breastfeeding mother
Arms & Interventions
Optive after the second anti-VEGF injection
Naive patients requiring intravitreal injection. Patients will be enrolled in this study within the 2 first intravitreal injections to assess quality of life and ocular discomfort without wetting agent (ie after the first injection) and with wetting agent (ie after the second injection)
Intervention: Optive
Outcomes
Primary Outcomes
Comparison of the overall scores of the ocular discomfort questionnaire after the 2 first intravitreal injection in naïve patients
Time Frame: within the 72h after the first and the second intravitreal injections